Completed NA INTERVENTIONAL 2-arm NCT00359073

Effect of Montelukast on Experimentally-Induced RV16 Infection in Asthma

Effect of Montelukast on Experimentally-Induced RV16 Infection in Volunteers With Mild Asthma

Sponsor: University of Wisconsin, Madison

Conditions Asthma

Updated 7 times since 2017 Last updated: Mar 12, 2018 Started: Oct 31, 2006 Primary completion: Jan 31, 2009 Completion: Jan 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Asthma and is currently completed. University of Wisconsin, Madison leads this study, which shows 7 recorded versions since 2006 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Dec 2021 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Dec 2021 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 2 earlier versions

Mar 2018 — Jun 2018 [monthly]

Completed NA
Jan 2017 — Mar 2018 [monthly]

Completed NA

First recorded

Oct 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Wisconsin, Madison

Data source: University of Wisconsin, Madison

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Madison, United States